These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 27085461)
1. HIC1 attenuates invasion and metastasis by inhibiting the IL-6/STAT3 signalling pathway in human pancreatic cancer. Hu B; Zhang K; Li S; Li H; Yan Z; Huang L; Wu J; Han X; Jiang W; Mulatibieke T; Zheng L; Wan R; Wang X; Hu G Cancer Lett; 2016 Jul; 376(2):387-98. PubMed ID: 27085461 [TBL] [Abstract][Full Text] [Related]
2. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway. Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418 [TBL] [Abstract][Full Text] [Related]
3. HIC1 interacts with and modulates the activity of STAT3. Lin YM; Wang CM; Jeng JC; Leprince D; Shih HM Cell Cycle; 2013 Jul; 12(14):2266-76. PubMed ID: 24067369 [TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer. Zhao G; Qin Q; Zhang J; Liu Y; Deng S; Liu L; Wang B; Tian K; Wang C Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S301-11. PubMed ID: 22552606 [TBL] [Abstract][Full Text] [Related]
5. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041 [TBL] [Abstract][Full Text] [Related]
6. REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2/STAT3 positive feedback loop. Liu X; Wang J; Wang H; Yin G; Liu Y; Lei X; Xiang M Cancer Lett; 2015 Jun; 362(1):45-60. PubMed ID: 25779676 [TBL] [Abstract][Full Text] [Related]
7. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
8. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4. Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351 [TBL] [Abstract][Full Text] [Related]
10. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Wang P; Chen L; Zhang J; Chen H; Fan J; Wang K; Luo J; Chen Z; Meng Z; Liu L Oncogene; 2014 Jan; 33(4):514-24. PubMed ID: 23334332 [TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer. Sun X; Qu Q; Lao Y; Zhang M; Yin X; Zhu H; Wang Y; Yang J; Yi J; Hao M BMC Cancer; 2019 Dec; 19(1):1180. PubMed ID: 31795965 [TBL] [Abstract][Full Text] [Related]
12. Neuropilin-1 (NRP-1) upregulated by IL-6/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms. Yang Y; Yang L; Li Y Hum Pathol; 2018 Nov; 81():192-200. PubMed ID: 30420046 [TBL] [Abstract][Full Text] [Related]
13. Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1. Huang C; Li H; Wu W; Jiang T; Qiu Z Oncol Rep; 2013 Sep; 30(3):1223-30. PubMed ID: 23817566 [TBL] [Abstract][Full Text] [Related]
14. Tumor-neuroglia interaction promotes pancreatic cancer metastasis. Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766 [No Abstract] [Full Text] [Related]
15. [Inhibitory effect of AG490 on invasion and metastasis of human pancreatic cancer cells in vitro]. Huang C; Qiu ZJ; Cao J; Huang KJ; Zhang F; Jiang T; Zhu L; Liu J Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):890-3. PubMed ID: 17533737 [TBL] [Abstract][Full Text] [Related]
16. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer. Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499 [TBL] [Abstract][Full Text] [Related]
17. BRM transcriptionally regulates miR-302a-3p to target SOCS5/STAT3 signaling axis to potentiate pancreatic cancer metastasis. Zhang Z; Li J; Guo H; Wang F; Ma L; Du C; Wang Y; Wang Q; Kornmann M; Tian X; Yang Y Cancer Lett; 2019 May; 449():215-225. PubMed ID: 30790683 [TBL] [Abstract][Full Text] [Related]
18. HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2. Cheng G; Sun X; Wang J; Xiao G; Wang X; Fan X; Zu L; Hao M; Qu Q; Mao Y; Xue Y; Wang J Cancer Res; 2014 Feb; 74(3):862-72. PubMed ID: 24295734 [TBL] [Abstract][Full Text] [Related]
19. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909 [TBL] [Abstract][Full Text] [Related]
20. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway. Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]